It can be seen from analysis on major blood grouping analyzer-related patent applications published in the 3 years from 2018 to 2021 that benefited from the basically stable original technologies of the industry; domestic enterprises have continuously increased R&D inputs, constantly improved technical innovation capability, made breakthroughs in many technologies, and developed a batch of core components of instruments with independent intellectual property rights through follow-on R&D strategy.

China plans to accelerate the establishment of a tiered healthcare delivery system, focusing on strengthening primary-level medical capacity to manage common and chronic diseases such as hypertension and diabetes, authorities said.

In recent years, because of the optimistic attitude about the development of IVD industry, various VC and PE investments are very active.

On December 19, at the 16th International Respiratory Symposium in Changshu, Abbott announced that it had joined the International Smart Health Alliance and signed an important strategic cooperation with the China Lung Cancer Prevention Alli

On December 18, 2020, Hipro biotechnology Corp announced the completion of the c-round financing of over 100 million YUAN.

CSRC has approved the registration of the initial public offering of Jiangsu HOB Biotech (HOB) Co., Ltd. on the science and technology innovation board.

Recently, TÜV SÜD Product Service GmbH an EU Notified Body certified the first IVDR CE certificate in the field of chemiluminescence in China, and its winner is Shenzhen New Industries Biomedical Engineering Co., Ltd.

View this email in Your Browse Official Website Click for more Timetable of CACLP CISCE 2021 will be continuously updated. Read More The 8th China IVD Industry Development Conference The 8th China IVD Industry Development Conference is sche

On December 8, 2020, Beckman Coulter, Inc. and Realcan signed a strategic cooperation agreement in Shanghai and held a cooperation exchange meeting.

Maccura and Hoyotek Bio obtained the CE for their COVID-19 products.

Hann Pang, currently vice president of business operations in China, will take over as the president of Thermo Fisher China.

According to the info. released by NMPA, the certificate of the new type of medical equipment of 2019-nCov nucleic acid reagent kit (CRISPR with immunochromatography method) which was published on Dec. 1st researched by Hangzhou ZC Bio-Sci &